Target intelligence / Profile preview

Eukaryotic 28S ribosomal RNA (28S rRNA)

Target
28S rRNA
Molecular classification
Ribozyme, Ribosomal RNA, Other
01

Overview

Eukaryotic 28S ribosomal RNA (28S rRNA) is the structural and catalytic core of the eukaryotic 60S large ribosomal subunit, serving as a ribozyme that facilitates the peptidyl transferase reaction during protein synthesis (NCBI, 2023). It features a highly conserved region known as the sarcin/ricin loop (SRL), which is essential for the binding of translation elongation factors eEF-1 and eEF-2 (PubMed, PMID: 11554172). This loop is the primary target for Ribosome-Inactivating Proteins (RIPs) like ricin and Shiga toxin, which irreversibly depurinate a specific adenine residue, thereby halting translation and inducing cell death (UniProt, P02879). Beyond its role in translation, 28S rRNA acts as a sensor for cellular stress; damage to its structure triggers the ribotoxic stress response, activating signaling cascades such as the p38 and JNK MAPK pathways (PubMed, PMID: 15688010). In a therapeutic context, 28S rRNA is targeted by experimental immunotoxins designed to deliver RIPs specifically to malignant cells (StatPearls, NBK557574). Its dysregulation is also increasingly recognized in the context of ribosomopathies and oncogenesis, where altered rRNA processing can drive disease progression (PubMed, PMID: 30639201). Furthermore, certain antibiotics and small molecules can bind to the peptidyl transferase center of the 28S rRNA to inhibit protein synthesis in eukaryotic cells or specific organelles (PubChem, CID 2520).

Other names
28S rRNALarge subunit ribosomal RNALSU rRNA28S ribosomal RNARN28S128S ribosomal RNA gene
02

Mechanism of action

Site-specific depurination of the sarcin/ricin loop (SRL) by N-glycosidases or competitive inhibition of the peptidyl transferase center, leading to the cessation of protein synthesis (PubMed, PMID: 11554172; PubChem, CID 2520).

03

Biological functions

Protein synthesisPeptidyl transferase activityRibotoxic stress responseCell deathOther
04

Disease associations

InfectionCancerOther
05

Safety considerations

Extreme systemic toxicityOff-target cytotoxicityVascular leak syndromeImmunogenicity of toxin conjugates
06

Interacting drugs

Ricin

7 more in the full profile.

07

Biomarkers

rRNA depurination fragmentsp38 MAPK activationJNK activation

Beyond the preview

Go deeper on Eukaryotic 28S ribosomal RNA (28S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic 28S ribosomal RNA (28S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call